A Phase IIB Randomized, Placebo-Controlled Trial of Pioglitazone for Oral Pre-Malignant Lesions: An Inter-Consortium Collaborative Study

Grant

Date/time Interval

  • March 1, 2010 - September 29, 2011
  • Total Award Amount

  • 79481.00
  • Direct Costs

  • 61395.00
  • Sponsor Award Id

  • 949N815
  • Contributor

  • Elmets M.D., Craig   Principal Investigator